Press Releases

Results Found (124)
April 6, 2009
YISSUM APPOINTS YAACOV MICHLIN AS CHIEF EXECUTIVE OFFICER

Yissum announced today the appointment of Yaacov Michlin as Chief Executive Officer, effective May 1, 2009. The Company also announced that Yehuda Yarmut, who until recently was Executive Vice President Licensing & IP, was promoted and appointed...

March 30, 2009
MERCK KGAA AND YISSUM SIGN R&D COLLABORATION AGREEMENT

Merck to sponsor three-year joint R&D program with Yissum's spin-off, QLight Nanotech, for the development of novel semiconductor nanoparticles technology for optical applications

March 19, 2009
YISSUM LICENSES TO VAN LEER VENTURES A SOFTWARE PLATFORM FOR MAXIMIZING PC...

Van Leer Ventures Establishes Valensum to Develop the Technology

February 4, 2009
YISSUM ANNOUNCES NANOTECHNOLOGY FOR INCREASED BIOAVAILABILITY OF COMPOUNDS...

Professor Nissim Garti from the Casali Institute of Applied Chemistry, Institute of Chemistry at the Hebrew University of Jerusalem has received the 2009 American Oil Chemists’ Society (AOCS) Stephen S. Chang Award for his invention of novel...

December 17, 2008
YISSUM LAUNCHES CLEANTECH PROGRAMME IN SUPPORT OF TECHNOLOGIES DEVELOPED AT...

Initial cleantech inventions chosen include technologies aimed at reducing polluting effects of fossil fuels and creating alternative clean energy sources

December 15, 2008
YISSUM SUBSIDIARY JEXYS PHARMACEUTICALS ANNOUNCES STRATEGIC R&D...

Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, announces today that its subsidiary Jexys Pharmaceuticals has signed a strategic research and development agreement with Teva Pharmaceuticals Industries Ltd. Under the...

November 12, 2008
BIOLINERX AND YISSUM SIGN A LICENSING AGREEMENT FOR THE DEVELOPMENT OF A...

Yissum the Technology Transfer Company of the Hebrew University of Jerusalem, and BioLineRx , a clinical stage drug development company, today announced that they have signed a worldwide exclusive license agreement for BioLineRx to develop and...

October 2, 2008
YISSUM ANNOUNCES A NOVEL METHOD FOR SWIFT AND ROBUST PATTERN RECOGNITION

Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, introduced today a novel method for real time, automatic, generic and robust pattern matching. The novel algorithm, developed by Professor Michael Werman and Ofir...

September 29, 2008
New YISSUM’S TECHNOLOGY TRANSFER INTERNATIONAL INTERNSHIP PROGRAM OPENING...

An international internship program has been running at Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, for the past two years. The program aims both to expand international relationships that will encourage new...

May 27, 2008
YISSUM INTRODUCES NOVEL DEVICE FOR IMPROVED SALIVA BASED MEDICAL DIAGNOSTICS

Technology Presented at ILSI BioMed Israel 2008 conference

March 11, 2008
YISSUM ANNOUNCES THE LAUNCH OF THE HEBREW UNIVERSITY’S GENETIC RESOURCE...

The Hebrew University Genetic Resource (HUGR) platform includes 15,000 DNA samples of Ashkenazi Jews

February 27, 2008
YISSUM ANNOUNCES THE DISCOVERY OF A NOVEL SMALL MOLECULE WITH POTENT...

cientists from the School of Pharmacy at the Hebrew University of Jerusalem discovered a novel orally available drug that prevents metastasis formation in various types of cancers.